Search Results for: Non-small cell lung cancer

May 8, 2020May 8, 2020

Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic.

Publication date: Apr 28, 2020 The COVID-19 pandemic is currently accelerating. Patients with locally advanced non-small cell lung cancer (LA-NSCLC) may require treatment in locations where resources are limited and ... Read more

March 16, 2020

Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning.

Precision Medicine Literature

Publication date: Mar 13, 2020 Non-small cell lung cancer (NSCLC) is one of the most common lung cancers worldwide. Accurate prognostic stratification of NSCLC can become an important clinical reference ... Read more

February 9, 2020February 9, 2020

Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.

Precision Medicine Literature

Publication date: Feb 07, 2020 Non-small cell lung cancer (NSCLC) is featured with complex genomic alterations. Molecular profiling of large cohort of NSCLC patients is thus a prerequisite for precision ... Read more

May 29, 2020May 29, 2020

RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer.

Melanoma Literature

Publication date: May 27, 2020 Recent efforts have revealed that long non-coding RNAs exert crucial roles in cancer initiation and progression. RHPN1-AS1 is a 2030?bp transcript from human chromosome 8q24, ... Read more

May 22, 2020May 22, 2020

Current panorama and challenges for neoadjuvant cancer immunotherapy.

Melanoma Literature

Publication date: May 20, 2020 Immune checkpoint inhibitors (ICI) may overcome cancer cells’ ability to evade the immune system and proliferate. The long-term benefit of ICI in the metastatic setting ... Read more

May 21, 2020May 21, 2020

Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience.

Melanoma Literature

Publication date: May 19, 2020 Introduction: Monoclonal antibodies directed against programmed cell death-1 (anti-PD-1) and its ligand (anti-PD-L1) showed a significant efficacy among different immunogenic metastatic tumors such as melanoma, ... Read more

May 15, 2020May 15, 2020

The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors.

Melanoma Literature

Publication date: May 12, 2020 Immune checkpoint inhibitors (ICI) have improved survival in numerous types of cancer. However, a great number of unselected patients still do not respond to ICI. ... Read more

May 8, 2020May 8, 2020

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.

Precision Medicine Literature

Publication date: May 05, 2020 Clinical implementation of tumor organoids for personalized medicine requires that pure tumor organoids can be reliably established. Here, we present our experience with organoid cultures ... Read more

May 7, 2020May 7, 2020

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy.

Melanoma Literature

Publication date: May 04, 2020 Response evaluation for cancer treatment consists primarily of clinical and radiological assessments. In addition, a limited number of serum biomarkers that assess treatment response are ... Read more

May 3, 2020May 3, 2020

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.

Melanoma Literature

Publication date: Apr 28, 2020 Immune checkpoint inhibitors have revolutionized treatment and outcome of melanoma and many other solid malignancies including non-small cell lung cancer (NSCLC) and renal cell carcinoma ... Read more